Imunon Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1995
Net Income	-19.51	-35.9	-20.77	-21.48	-16.85	Upgrade
Depreciation & Amortization	0.72	0.73	0.7	0.74	0.72	Upgrade
Share-Based Compensation	0.76	2.67	3.76	1.85	2.29	Upgrade
Other Operating Activities	-0.99	9.4	0.08	3.27	-6.42	Upgrade
Operating Cash Flow	-19.02	-23.1	-16.22	-15.62	-20.26	Upgrade
Capital Expenditures	-0.45	-0.27	-0.31	-0.02	-0.35	Upgrade
Change in Investments	11.46	8.55	-29.81	7.94	6.29	Upgrade
Investing Cash Flow	11.01	8.28	-30.12	7.92	5.94	Upgrade
Share Issuance / Repurchase	2.78	6.72	54.2	23.18	7.84	Upgrade
Debt Issued / Paid	-6.42	0	0.57	-5.2	0	Upgrade
Financing Cash Flow	-3.64	6.72	54.77	17.98	7.84	Upgrade
Net Cash Flow	-11.65	-8.09	8.42	10.29	-6.48	Upgrade
Free Cash Flow	-19.47	-23.36	-16.54	-15.64	-20.61	Upgrade
Free Cash Flow Margin	-	-4672.94%	-3307.04%	-3127.55%	-4121.63%	Upgrade
Free Cash Flow Per Share	-2.15	-3.27	-3.05	-7.34	-14.16	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).